1. Home
  2. VTSI vs CUE Comparison

VTSI vs CUE Comparison

Compare VTSI & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTSI
  • CUE
  • Stock Information
  • Founded
  • VTSI 1993
  • CUE 2014
  • Country
  • VTSI United States
  • CUE United States
  • Employees
  • VTSI N/A
  • CUE N/A
  • Industry
  • VTSI Miscellaneous manufacturing industries
  • CUE Biotechnology: Pharmaceutical Preparations
  • Sector
  • VTSI Consumer Discretionary
  • CUE Health Care
  • Exchange
  • VTSI Nasdaq
  • CUE Nasdaq
  • Market Cap
  • VTSI 70.9M
  • CUE 77.3M
  • IPO Year
  • VTSI N/A
  • CUE 2018
  • Fundamental
  • Price
  • VTSI $6.83
  • CUE $1.13
  • Analyst Decision
  • VTSI Strong Buy
  • CUE Strong Buy
  • Analyst Count
  • VTSI 2
  • CUE 5
  • Target Price
  • VTSI $14.50
  • CUE $5.00
  • AVG Volume (30 Days)
  • VTSI 76.0K
  • CUE 378.2K
  • Earning Date
  • VTSI 11-12-2024
  • CUE 11-14-2024
  • Dividend Yield
  • VTSI N/A
  • CUE N/A
  • EPS Growth
  • VTSI N/A
  • CUE N/A
  • EPS
  • VTSI 0.53
  • CUE N/A
  • Revenue
  • VTSI $31,771,647.00
  • CUE $9,532,000.00
  • Revenue This Year
  • VTSI N/A
  • CUE $105.39
  • Revenue Next Year
  • VTSI $24.06
  • CUE N/A
  • P/E Ratio
  • VTSI $13.00
  • CUE N/A
  • Revenue Growth
  • VTSI N/A
  • CUE 149.53
  • 52 Week Low
  • VTSI $5.63
  • CUE $0.45
  • 52 Week High
  • VTSI $17.68
  • CUE $3.20
  • Technical
  • Relative Strength Index (RSI)
  • VTSI 45.65
  • CUE 45.52
  • Support Level
  • VTSI $6.79
  • CUE $0.92
  • Resistance Level
  • VTSI $8.00
  • CUE $1.09
  • Average True Range (ATR)
  • VTSI 0.34
  • CUE 0.11
  • MACD
  • VTSI -0.09
  • CUE 0.00
  • Stochastic Oscillator
  • VTSI 14.50
  • CUE 45.71

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company includes installation, training, limited warranties, service agreements and related support. The company sells and supports use of force training and marksmanship firearms training systems and accessories for law enforcement, military or civilian use. The product line of the company includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire and other accessories.

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.

Share on Social Networks: